Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High vs low protamine-to-heparin dosing in CABG surgery
2012-003359-12Phase 4Active
- Sponsor
- VU University Medical Center
- Start
- Aug 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of protamine in coronary arteriosclerosis (2 arms), sponsored by VU University Medical Center. Primary endpoint: Postoperative 24-hour blood loss. Started Aug 2013; status: active.
02
Drugs
protamine
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on 2012-003359-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-003359-12.